Non-invasive test for bladder cancer

Israel’s BioLight Life Sciences Investments announced that its CellDetect non-invasive test for detecting bladder cancer in urine has obtained CE Marking, enabling the product to be marketed and sold in Europe and other countries.

http://www.bio-light.co.il/blog/eu-ce-mark-for-celldetect-non-invasive-test-for-detecting-recurrence-of-bladder-cancer/

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.